ElMaestro
Hero

Denmark,
2017-11-24 19:33

Posting: # 18002
Views: 966
 

 FDA views on the use of R and other nonproprietary software [Software]

Hi all,

I stumbled upon this presentation by chance.

The future looks bright for R.

A good weekend to all of you.

if (3) 4

x=c("Foo", "Bar")
b=data.frame(x)
typeof(b[,1]) ##aha, integer?
b[,1]+1 ##then let me add 1



Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,271 posts in 4,099 threads, 1,315 registered users;
online 15 (1 registered, 14 guests [including 14 identified bots]).

It’s easy to lie with statistics;
it is easier to lie without them.    Frederick Mosteller

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5